One-Of-A-Kind Lions In London VIP Experience to Help Fund A Cure for Type 1 Diabetes

in

PRESS RELEASE

DETROIT – (April 21, 2014) – On Friday, May 2, 2014, Breakthrough T1D will auction a one-of-a-kind Lions In London VIP Experience as part of its 29th Annual Promise Ball Gala at the MGM Grand in Detroit to help fund research toward finding a cure for type 1 diabetes (T1D). Since 2005, the Promise Ball Gala has raised more than $5 million to help find a cure for T1D.

The live auction package allows the winner to attend the Detroit Lions-Atlanta Falcons game in London, England on October 26, 2014, the first Detroit Lions regular season game to be played outside of the United States, including:

  • Two game tickets
  • Two pre-game sideline passes
  • Autographed memorabilia

All of the above donated by The Detroit Lions, plus:

  • Round-trip airfare, donated by Delta Airlines
  • Hotel accommodations, donated by Ford Motor Company

For Gala information, contact Susan Kossik at 248-936-1281 or email skossik@BreakthroughT1D.org.

As many as three million Americans have type 1 diabetes, and each year, more than 15,000 children and 15,000 adults – approximately 80 people per day – are diagnosed with T1D in the U.S. The prevalence of T1D in Americans younger than 20 rose by 23 percent between 2001 and 2009.

About Breakthrough T1D

Breakthrough T1D is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents and adults with this disease, Breakthrough T1D is now the largest charitable supporter of T1D research. The goal of Breakthrough T1D research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. Breakthrough T1D collaborates with a wide spectrum of partners who share this goal.

Since its founding in 1970, Breakthrough T1D has awarded more than $1.8 billion to diabetes research. Past Breakthrough T1D efforts have helped to significantly advance the care of people with this disease and have expanded the critical scientific understanding of T1D. Breakthrough T1D will not rest until T1D is fully conquered. More than 80 percent of Breakthrough T1D’s expenditures directly support research and research-related education.